Trial intelligence / Profile preview

Immune Response to Influenza Vaccine in JIA Children

NCT03833271Phase 1Completed

Sponsor
University of Pécs
Start
Oct 2018
Primary completion
Sep 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 1, open-label trial of 3Fluart in influenza (3 arms), sponsored by University of Pécs. Primary endpoints: Immune function comparison and Rate of seroconversion. Started Oct 2018; status: completed.

02

Drugs

3Fluart
03

Conditions

influenza

Beyond the preview

Go deeper on NCT03833271.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03833271.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call